Salbutamol safety in children under 2 years of age with acute wheezing: a meta-analysis of randomised controlled trials.

Luca PierantoniMuratore EdoardoCerasi SaraZama DanieleChiara Del BonoGori DavideRiccardo MasettiMarcello Lanari

Published in: Archives of disease in childhood (2024)

Inhaled salbutamol can be safely used in children under 2 years of age with acute wheeze with the administration via a metered-dose inhaler being potentially safer than a nebulised formulation. Neither of the formulations was associated with severe adverse effects.

Keyphrases

liver failure
young adults
respiratory failure
drug induced
aortic dissection
cystic fibrosis
early onset